Patent · US Active

Transfection agent

US9133484B2 · kind B2 · utility

3Cited by
0References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 26, 2009
Grant dateSep 15, 2015
Priority date—
Expiry dateSep 23, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K47/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A transfection agent is provided that has lower toxicity and can be applied in the clinical setting. The transfection agent comprises a peptide surfactant.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.